Patient Testimonials

ENT Research at the California Sinus Centers

 


Otolaryngology, ENT & Sinus News Provided by the California Sinus Centers

Adenoid cystic carcinoma of the head and neck - Corrected Proof

January 6, 2012, 12:00 pm by American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

Abstract: Purpose: To report our experience using radiotherapy alone or combined with surgery to treat adenoid cystic carcinoma of the head and neck.Materials and methods: Radiotherapy alone or combined with surgery was used to treat 120 previously untreated patients with adenoid cystic carcinoma (ACC) of the head and neck from August 1966 to March 2008. Patients were treated with curative intent. American Joint Committee on Cancer stage distribution was,T0 (n = 1), T1 (n = 26), T2 (n = 25), T3 (n = 14), T4 (n = 54), N0 (n = 113), N1 (n = 2), N2a (n = 1), N2b (n = 2), and N2c (n = 2). Treatment included surgery with postoperative radiotherapy (n = 71), radiotherapy alone (n = 46), and preoperative radiotherapy and surgery (n = 3). Incidental and clinical perineural invasion was found in 41 (34%) and 35 (29%) patients, respectively. Median follow-up was 8.6 and 11.6 years overall and among living patients, respectively.Results: The10-year overall, cause-specific, and distant metastasis-free survival rates, respectively, were as follows: radiotherapy alone, 37%, 46%, and 76%; surgery and radiotherapy, 57%, 71%, and 62%; and overall, 50%. The10-year local control rates were as follows: radiotherapy alone, 36%; surgery and radiotherapy, 84%; and overall, 65%. The 10-year neck control rates were as follows: elective nodal irradiation (ENI), 98%; no ENI, 89%; and overall, 95%.Conclusions: Surgery and adjuvant radiotherapy offer the best chance for cure for patients with resectable adenoid cystic carcinomas of the head and neck. Some patients with advanced, incompletely resectable disease can be cured with radiotherapy alone. ENI should be considered for primary sites located in lymphatic-rich regions.

Read the full article


More from American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

Ototoxicity of Burow solution on the guinea pig cochlea - Corrected Proof
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: May 7, 2012, 12:00 pm
Abstract: Purpose of the study: The aim of the present study was to evaluate the ototoxicity of Burow solution.Procedures: Compound action potentials (CAPs) of the eighth nerve were measured before and 30

Vocal characteristics in patients with thyroiditis - Corrected Proof
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: May 7, 2012, 12:00 pm
Abstract: Objective: The aim of the present study was to describe the vocal characteristics of patients with thyroiditis in a clinical setting.Materials and methods: A total of 17 consecutive patients with the

Bilateral enlarged vestibular aqueduct with associated bilateral Mondini dysplasia - Corrected Proof
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: April 26, 2012, 12:00 pm
Abstract: Enlarged Vestibular Aqueduct (EVA) and Mondini's dysplasia ( incomplete partitioning type II) are entitites that have been fairly well described in the literature as potential causes of hearing loss in the

Pattern of expression of cyclooxygenase-2 in malignant transformation of sinonasal inverted papilloma - Corrected Proof
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: April 26, 2012, 12:00 pm
Abstract: Objective: Cyclooxygenases (COXs) are enzymes that catalyze the conversion of arachidonic acid to prostaglandins. Many studies have suggested that COX-2, the inducible form of COX, is important in carcinogenesis. However, little

Etiology of unilateral hearing loss in a national hereditary deafness repository - Corrected Proof
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: April 26, 2012, 12:00 pm
Abstract: Purpose: The aim of this study was to characterize the genetic, audiologic, and epidemiologic characteristics of unilateral hearing loss (HL) in a national hereditary deafness repository.Materials and Methods: This is a

 

NOTICE: The CSC web site "Otolaryngology ENT Industry News" has data and links presented by way of the above mentioned RSS news feeds. We offer this industry news for your convenience and education. CSC does not review the information provided in this section. CSC does not assume any endorsement or present these third-party feeds and links as CSC belief or in conjunction with CSC whatsoever. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the California Sinus Centers. For more information, please see our disclaimer.